Lemaitre Vascular (LMAT) Capital Expenditures (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Capital Expenditures for 17 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 72.35% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $9.2 million, a 42.16% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, down 2.57% from the prior year.
• Capital Expenditures was $2.3 million for Q2 2026 at Lemaitre Vascular, down from $2.8 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $2.8 million in Q2 2023 and troughed at $460000.0 in Q3 2022.
• A 5-year average of $1.6 million and a median of $1.5 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures sank 74.64% in 2022 and surged 297.39% in 2023, its largest moves.
• Over 5 years, Capital Expenditures stood at $1.3 million in 2022, then grew by 1.51% to $1.3 million in 2023, then soared by 59.81% to $2.0 million in 2024, then decreased by 13.06% to $1.8 million in 2025, then jumped by 30.16% to $2.3 million in 2026.
• The last three Capital Expenditures figures came in at $2.3 million (Q2 2026), $2.8 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.